Identification of a novel SIRT7 inhibitor as anticancer drug candidate

Ji Hye Kim, Dahee Kim, Suk Joon Cho, Kwan Young Jung, Jong-Hoon Kim, Jun Mi Lee, Hee Jung Jung, Kwang Rok Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sirtuins (SIRT1-7), a class of deacetylases, play major roles in DNA damage repair, aging, and metabolism in yeast and in mammals. SIRT7 is localized in the nucleolus. It regulates cellular processes, including genomic stability, rDNA transcription, and cell proliferation, and plays a role in tumorigenesis. SIRT7 deacetylates its substrates histone H3 (at lysine 18) and p53. p53, a tumor suppressor, induces apoptosis or cell cycle arrest and is stabilized by acetylation. p53 deacetylation at K382 by SIRT7 suppressed cancer cell growth by attenuating p53 activity. Therefore, identification of novel SIRT7 enzyme inhibitors is important. In this study, we found a novel inhibitor of SIRT7 (ID: 97491) that decreased SIRT7 activity in a dose-dependent manner. ID: 97491 induced expression of p53 and its acetylation by inhibited SIRT7. Moreover, ID: 97491 upregulated apoptotic effects through the caspase related proteins and inhibited cancer growth in vivo. The study results suggest that ID: 97491 can be a potential candidate to inhibit the deacetylase activity of SIRT7 and prevent tumor progression by increasing p53 stability through acetylation at K373/382.

Original languageEnglish
JournalBiochemical and Biophysical Research Communications
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Acetylation
Tumors
Sirtuins
Pharmaceutical Preparations
Neoplasms
Mammals
Cell proliferation
Cell growth
Enzyme Inhibitors
Transcription
Caspases
Ribosomal DNA
Metabolism
Histones
Yeast
Lysine
Genomic Instability
Repair
Growth
Aging of materials

Keywords

  • Apoptosis
  • Deacetylation
  • Inhibitor
  • p53
  • SIRT7

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Identification of a novel SIRT7 inhibitor as anticancer drug candidate. / Kim, Ji Hye; Kim, Dahee; Cho, Suk Joon; Jung, Kwan Young; Kim, Jong-Hoon; Lee, Jun Mi; Jung, Hee Jung; Kim, Kwang Rok.

In: Biochemical and Biophysical Research Communications, 01.01.2018.

Research output: Contribution to journalArticle

Kim, Ji Hye ; Kim, Dahee ; Cho, Suk Joon ; Jung, Kwan Young ; Kim, Jong-Hoon ; Lee, Jun Mi ; Jung, Hee Jung ; Kim, Kwang Rok. / Identification of a novel SIRT7 inhibitor as anticancer drug candidate. In: Biochemical and Biophysical Research Communications. 2018.
@article{1ee2d5cb6ec64dd4beaa4bda711cb003,
title = "Identification of a novel SIRT7 inhibitor as anticancer drug candidate",
abstract = "Sirtuins (SIRT1-7), a class of deacetylases, play major roles in DNA damage repair, aging, and metabolism in yeast and in mammals. SIRT7 is localized in the nucleolus. It regulates cellular processes, including genomic stability, rDNA transcription, and cell proliferation, and plays a role in tumorigenesis. SIRT7 deacetylates its substrates histone H3 (at lysine 18) and p53. p53, a tumor suppressor, induces apoptosis or cell cycle arrest and is stabilized by acetylation. p53 deacetylation at K382 by SIRT7 suppressed cancer cell growth by attenuating p53 activity. Therefore, identification of novel SIRT7 enzyme inhibitors is important. In this study, we found a novel inhibitor of SIRT7 (ID: 97491) that decreased SIRT7 activity in a dose-dependent manner. ID: 97491 induced expression of p53 and its acetylation by inhibited SIRT7. Moreover, ID: 97491 upregulated apoptotic effects through the caspase related proteins and inhibited cancer growth in vivo. The study results suggest that ID: 97491 can be a potential candidate to inhibit the deacetylase activity of SIRT7 and prevent tumor progression by increasing p53 stability through acetylation at K373/382.",
keywords = "Apoptosis, Deacetylation, Inhibitor, p53, SIRT7",
author = "Kim, {Ji Hye} and Dahee Kim and Cho, {Suk Joon} and Jung, {Kwan Young} and Jong-Hoon Kim and Lee, {Jun Mi} and Jung, {Hee Jung} and Kim, {Kwang Rok}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2018.11.120",
language = "English",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Identification of a novel SIRT7 inhibitor as anticancer drug candidate

AU - Kim, Ji Hye

AU - Kim, Dahee

AU - Cho, Suk Joon

AU - Jung, Kwan Young

AU - Kim, Jong-Hoon

AU - Lee, Jun Mi

AU - Jung, Hee Jung

AU - Kim, Kwang Rok

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Sirtuins (SIRT1-7), a class of deacetylases, play major roles in DNA damage repair, aging, and metabolism in yeast and in mammals. SIRT7 is localized in the nucleolus. It regulates cellular processes, including genomic stability, rDNA transcription, and cell proliferation, and plays a role in tumorigenesis. SIRT7 deacetylates its substrates histone H3 (at lysine 18) and p53. p53, a tumor suppressor, induces apoptosis or cell cycle arrest and is stabilized by acetylation. p53 deacetylation at K382 by SIRT7 suppressed cancer cell growth by attenuating p53 activity. Therefore, identification of novel SIRT7 enzyme inhibitors is important. In this study, we found a novel inhibitor of SIRT7 (ID: 97491) that decreased SIRT7 activity in a dose-dependent manner. ID: 97491 induced expression of p53 and its acetylation by inhibited SIRT7. Moreover, ID: 97491 upregulated apoptotic effects through the caspase related proteins and inhibited cancer growth in vivo. The study results suggest that ID: 97491 can be a potential candidate to inhibit the deacetylase activity of SIRT7 and prevent tumor progression by increasing p53 stability through acetylation at K373/382.

AB - Sirtuins (SIRT1-7), a class of deacetylases, play major roles in DNA damage repair, aging, and metabolism in yeast and in mammals. SIRT7 is localized in the nucleolus. It regulates cellular processes, including genomic stability, rDNA transcription, and cell proliferation, and plays a role in tumorigenesis. SIRT7 deacetylates its substrates histone H3 (at lysine 18) and p53. p53, a tumor suppressor, induces apoptosis or cell cycle arrest and is stabilized by acetylation. p53 deacetylation at K382 by SIRT7 suppressed cancer cell growth by attenuating p53 activity. Therefore, identification of novel SIRT7 enzyme inhibitors is important. In this study, we found a novel inhibitor of SIRT7 (ID: 97491) that decreased SIRT7 activity in a dose-dependent manner. ID: 97491 induced expression of p53 and its acetylation by inhibited SIRT7. Moreover, ID: 97491 upregulated apoptotic effects through the caspase related proteins and inhibited cancer growth in vivo. The study results suggest that ID: 97491 can be a potential candidate to inhibit the deacetylase activity of SIRT7 and prevent tumor progression by increasing p53 stability through acetylation at K373/382.

KW - Apoptosis

KW - Deacetylation

KW - Inhibitor

KW - p53

KW - SIRT7

UR - http://www.scopus.com/inward/record.url?scp=85057413668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057413668&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2018.11.120

DO - 10.1016/j.bbrc.2018.11.120

M3 - Article

C2 - 30503501

AN - SCOPUS:85057413668

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

ER -